<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated whether the <z:chebi fb="0" ids="35457">angiotensin converting enzyme inhibitor</z:chebi>, <z:chebi fb="0" ids="8774">ramipril</z:chebi>, could attenuate white matter lesions caused by <z:hpo ids='HP_0011010'>chronic</z:hpo> hypoperfusion in the rat, and whether suppression of <z:mp ids='MP_0003674'>oxidative stress</z:mp> is involved in the resulting neuroprotection </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="0" ids="8774">ramipril</z:chebi> treatment group showed significant protection from development of white matter lesions in the optic tract, the anterior commissure, the corpus callosum, the internal capsule and the caudoputamen </plain></SENT>
<SENT sid="2" pm="."><plain>The level of malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) and the oxidized <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSSG)/total <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH t) ratio was also significantly decreased in the <z:chebi fb="0" ids="8774">ramipril</z:chebi> group compared to the vehicle-treated group </plain></SENT>
<SENT sid="3" pm="."><plain>These results suggest that <z:chebi fb="0" ids="8774">ramipril</z:chebi> can protect against white matter lesions that result from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> due to its effects on free radical scavenging </plain></SENT>
<SENT sid="4" pm="."><plain>Further efficacy should be studied in the treatment of <z:e sem="disease" ids="C0241832" disease_type="Disease or Syndrome" abbrv="">cerebrovascular insufficiency</z:e> states and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>